BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.16
+0.68 (0.74%)
At close: Jul 20, 2026, 4:00 PM EDT
90.98
-1.18 (-1.28%)
After-hours: Jul 20, 2026, 4:55 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.31 billion as of July 20, 2026. Its market cap has decreased by -13.97% in one year.
Market Cap
23.31B
Enterprise Value
7.90B
1-Year Change
-13.97%
Ranking
Category
Stock Price
$92.16
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.31B, an increase of 678.16%. That is a compound annual growth rate of 35.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 23.31B | 1.81% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 35.71B |
| BeOne Medicines AG | 34.69B |
| Royalty Pharma | 33.50B |
| Roivant Sciences | 24.82B |
| Moderna | 24.53B |
| Insmed | 23.48B |
| Incyte | 23.42B |
| Genmab | 17.56B |